Stay updated on PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. No visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-03-11T15:18:52.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision v3.4.2 was added and the government funding notice was removed; Revision v3.4.1 was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:30:39.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A system-wide funding notice about NIH operations was added. The site revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:00:39.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary UI has been added and there are small labeling/capitalization tweaks (e.g., QC criteria label, FEAR Act data). The site revision has been updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-27T23:46:00.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a minor revision update (Revision: v3.3.4) replacing the previous v3.3.3. No substantive changes to study details or page layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:46:36.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed.
    Difference
    0.1%
    Check dated 2025-12-23T17:18:36.000Z thumbnail image

Stay in the know with updates to PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.